NCT06832384 Intensive Physiotherapy in Children Affected by Posterior Fossa Tumors
| NCT ID | NCT06832384 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Eugenio Medea |
| Condition | Posterior Fossa Tumor |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2023-01-19 |
| Primary Completion | 2026-01-19 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2023-01-19 with a primary completion date of 2026-01-19.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of the current study is to describe the effectiveness of conventional and intensive physiotherapeutic intervention in improving gross motor skills (i.e. postural changes, walking and balance skills) in children affected by posterior fossa tumors
Eligibility Criteria
Inclusion Criteria: * subjects who underwent to surgical resection of tumors located in posterior fossa, age between 0 and 25 years Exclusion Criteria: * Subjects that are currently addressed to rehabilitative protocols availing of technological devices
Frequently Asked Questions
Who can join the NCT06832384 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, up to 25 Years, studying Posterior Fossa Tumor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06832384 currently recruiting?
Yes, NCT06832384 is actively recruiting participants. Visit ClinicalTrials.gov or contact IRCCS Eugenio Medea to inquire about joining.
Where is the NCT06832384 trial being conducted?
This trial is being conducted at Brindisi, Italy, Bosisio Parini, Italy, Conegliano, Italy.
Who is sponsoring the NCT06832384 clinical trial?
NCT06832384 is sponsored by IRCCS Eugenio Medea. The trial plans to enroll 40 participants.